Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

IL‐28A (IFN‐λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease

Open access
Koltsida, Ourania, Hausding, Michael, Stavropoulos, Athanasios, Koch, Sonja, Tzelepis, George, Übel, Caroline, Kotenko, Sergei V., Sideras, Paschalis, Lehr, Hans A., Tepe, Marcus, Klucher, Kevin M., Doyle, Sean E., Neurath, Markus F., Finotto, Susetta, Andreakos, Evangelos·2011·EMBO Molecular Medicine

Abstract

IL‐28 (IFN‐λ) cytokines exhibit potent antiviral and antitumor function but their full spectrum of activities remains largely unknown. Recently, IL‐28 cytokine family members were found to be profoundly down‐regulated in allergic asthma. We now reveal a novel role of IL‐28 cytokines in inducing type 1 immunity and protection from allergic airway disease. Treatment of wild‐type mice with recombinant or adenovirally expressed IL‐28A ameliorated allergic airway disease, suppressed Th2 and Th17 responses and induced IFN‐γ. Moreover, abrogation of endogenous IL‐28 cytokine function in IL‐28Rα −/− mice exacerbated allergic airway inflammation by augmenting Th2 and Th17 responses, and IgE levels. Central to IL‐28A immunoregulatory activity was its capacity to modulate lung CD11c + dendritic cell (DC) function to down‐regulate OX40L, up‐regulate IL‐12p70 and promote Th1 differentiation. Consistently, IL‐28A‐mediated protection was absent in IFN‐γ −/− mice or after IL‐12 neutralization and could be adoptively transferred by IL‐28A‐treated CD11c + cells. These data demonstrate a critical role of IL‐28 cytokines in controlling T cell responses in vivo through the modulation of lung CD11c + DC function in experimental allergic asthma. →See accompanying Closeup by Michael R Edwards and Sebastian L Johnston http://dx.doi.org/10.1002/emmm.201100143

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201100142

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 207

Metadata

Authors
Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Übel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., Klucher, K. M., Doyle, S. E., Neurath, M. F., Finotto, S., & Andreakos, E.
Venue
EMBO Molecular Medicine
Published
2011-05-03
Volume
3
Issue
6
Pages
348-361
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W1834477603
Cited by
207
References
2
FWCI
8.28
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL‐28A (IFN‐λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. https://app.cochat.ai/papers/10.1002/emmm.201100142
The paper
Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Übel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., Klucher, K. M., Doyle, S. E., Neurath, M. F., Finotto, S., & Andreakos, E. (2011). IL‐28A (IFN‐λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201100142

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.